Red light therapy devices are everywhere. They come as panels, masks, wraps, and blankets. Their marketing often sounds the same: reduce inflammation, speed up recovery, and boost energy. But the technology inside these devices varies. That difference determines whether the light reaches the tissue that needs it most.
For people dealing with joint pain, chronic inflammation, or slow recovery after workouts, the distinction between red light LEDs and infrared lasers is not a minor technical detail. It is the difference between surface-level relief and deep-tissue results.
What red light therapy does
Red light therapy is part of a broader category called photobiomodulation, or PBM. This uses red and near-infrared light to stimulate healing, relieve pain, and reduce inflammation at the cellular level.
The science is well-established. The main target of PBM is cytochrome c oxidase, an enzyme in the mitochondria that acts as the cell’s main energy engine. When light hits this enzyme, it triggers a cascade of effects: increased ATP production, a brief burst of reactive oxygen species, a rise in nitric oxide, and modulation of calcium levels.
What makes PBM relevant for inflammation is what happens next. Those secondary signals activate transcription factors that improve cell survival, reduce oxidative stress, and dial down inflammatory markers. Research has shown that PBM can modulate NF-kB pathways in normal cells while reducing inflammatory markers in already-activated inflammatory cells. It is not just stimulating; it is regulating.
How LEDs work
LEDs, or light-emitting diodes, are the most common delivery method in consumer red light therapy devices. They emit light across a broad area, making them good for surface-level coverage. This includes skin health, wound healing, and general circulation support.
A typical red light LED panel emitting at 660nm can penetrate a few millimeters into the skin, reaching the epidermis and upper dermis with relative ease. For skin-focused goals, LEDs are effective. They are also relatively affordable to manufacture, which is why they appear in everything from $30 face masks to $500 full-body panels. But their diffuse, non-coherent light has a limit when it comes to depth of penetration. That limit matters when the target is a joint, a tendon, or deep muscle tissue.
How infrared lasers work
Lasers operate differently. Instead of scattering light in multiple directions, a laser emits a coherent, focused beam. Photons travel in the same direction, at the same wavelength, in phase with each other. This coherence allows laser light to penetrate significantly deeper into tissue than an LED emitting at the same wavelength.
Near-infrared lasers operating at 808nm are well-studied for their interaction with mitochondria. Research found that 808nm NIR light directly enhances Complex IV activity in isolated mitochondria. This is the exact chromophore that initiates PBM’s anti-inflammatory cascade. The laser is not just reaching deeper tissue; it is triggering the precise biological mechanism that drives inflammation reduction at the cellular level.
A separate study found that photobiomodulation therapy reversed all inflammatory parameters in experimental models, both vascular and cellular. This underscores how targeted, sufficient-dose light delivery can produce meaningful anti-inflammatory outcomes.
The key difference: depth of penetration and cellular reach
LEDs are broad and shallow. Lasers are focused and deep. For inflammation in a knee joint, a hip flexor, or a shoulder tendon, the tissue that needs treatment sits centimeters below the skin surface. That is beyond what most LED devices can reliably access.
A comprehensive review confirmed that PBM reduces joint inflammation in both rheumatoid arthritis and osteoarthritis using near-infrared light. It also noted that specific parameters, including wavelength, power density, and irradiation time, significantly affect outcomes. Device specs are not just marketing language. They are the variables that determine whether light therapy works for a specific goal.
Why the combination is more effective than either alone
LEDs and lasers are not competing technologies. They are complementary. LEDs provide broad surface coverage, supporting circulation, skin-level tissue repair, and a wider treatment area. Lasers deliver concentrated energy deep into joints and connective tissue, where inflammation tends to originate.
A meta-analysis of nine randomized controlled trials found that low-level laser therapy significantly improved pain and stiffness compared to placebo. The trial that used combined LLLT and LED phototherapy showed significant improvement across most outcomes, suggesting the dual approach may offer additive benefits that neither technology achieves alone.
Using only LEDs leaves the deeper inflammatory source largely untreated. Using only a laser may miss the broader tissue environment surrounding the joint. Together, they cover the full spectrum of what light therapy can do.
What to look for in a dual-technology device
Not all combination devices are built equally. Here is what the specs mean when evaluating a device:
Wavelength: 660nm is the sweet spot for red light LEDs targeting surface tissue. 808nm is the most studied near-infrared wavelength for deep tissue and mitochondrial activation.
Power density: Higher is not always better. There is a well-documented biphasic dose response in PBM. Too little light has no effect. Too much can be inhibitory. Optimal dosing matters.
Skin-level contact: Light intensity drops off rapidly with distance. A device that maintains direct skin contact delivers a more consistent, therapeutically relevant dose than one held inches away.
Laser classification: Medical-grade lasers, Class 1 or Class 3B, indicate the device is operating at clinically meaningful power levels.
How the Kineon MOVE+ delivers both
The Kineon MOVE+ was designed around the dual-technology principle. Each module contains 8 × 660nm deep red LEDs and 10 × 808nm infrared lasers. These are the two wavelengths with the strongest evidence base for surface coverage and deep-tissue anti-inflammatory effects.
The infrared lasers in the MOVE+ are Class 1 medical-grade, operating at 5mW per laser diode and 50mW per module. The device uses a modular, wearable design that keeps the light in direct contact with the skin. This eliminates the power loss that comes with distance-based panels. The result is a consistent, targeted dose delivered exactly where it is needed, whether that is a knee, shoulder, elbow, or ankle.
Kineon MOVE+ is priced at $499, down from $699. A code MGB10 offers an additional $50 discount on the order.
The takeaway
Red light therapy works, but not all devices work the same way. The choice between LEDs and lasers, or a combination of both, depends on the target tissue. For surface-level concerns, LEDs are sufficient. For deep-tissue inflammation in joints and connective tissue, lasers are necessary. Devices that combine both technologies offer the most complete approach to reducing inflammation and supporting recovery.
